Resources

Improving diabetes patient outcomes in Indonesia

Helping patients managing their insulin treatment

Diabetes affects half a billion people around the globe. Its treatment greatly impacts the patient’s everyday life: patients must measure their glucose rates, self-administer insulin injections, adjust their lifestyles, and more. Indonesians face specific issues linked to the cultural characteristics of the country. Glucometers and needles are not always reimbursed, leading to low levels of use and increased risk of health-related issues.
The local diet consists mainly of rice-based meals particularly rich in sugar. In addition, preconceived ideas about insulin usage are common among the
Indonesian population.
In this context, our client, a global pharmaceutical leader in diabetes, needed to build an educational program for patients suffering from type 2 diabetes and treated with insulin that integrated the cultural specificities of the Indonesian population.

 

Read the full success story and be inspired for your patient engagement strategy like 80+ cutomers from top20 pharma companies who trusted us.

Choose in the menu.


Share

See also

Scientific communications

A multiple-cohort analysis of the SPUR 6/24 patient-reported adherence tool

Articles

Clinical Ink and Observia: Pioneering Personalized Patient Engagement in Clinical Trials

News

By your side in 2024: Happy Holidays from Observia!

Accès plateformes